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We have studied the effect of VEGF121 homodimer and VEGF121/165 heterodimer on the chorioallantoic membrane (CAM)
of 13-day-old chick embryos. The factors were applied in doses of 2±4 mg and the effects were evaluated macroscopically
after 2 and 3 days. Histological studies were performed on semi- and ultrathin sections. Proliferation was studied according
to the BrdU±anti-BrdU method on whole mounts and sections. The labeling density was quanti®ed in whole mounts. The
fractal dimension, D, of the vascular tree was assessed as a value for vascular bifurcation density. Both forms of VEGF
induce brush-like vessel formation in the precapillary region. New capillaries are found in the stroma of the CAM, which
normally does not contain capillaries. Our results show that VEGF121 is a speci®c endothelial cell mitogen. A fourfold
increase of BrdU-labeled endothelial cells is found after VEGF121 application. The fractal dimension of the vascular tree
increases from 1.26 in the controls to 1.44 (VEGF121) and 1.41 (VEGF121/165). The endothelial cells of the newly formed
capillaries possess many mitochondria and micropinocytotic vesicles, but no fenestrations. These capillaries are obviously
formed by intussusceptive microvascular growth. Signs of sprouting are almost absent. An effect on the lymphatic vessels
of the CAM is not detectable. Compared to VEGF165 and VEGF121/165 , VEGF121 diffuses over a slightly greater distance.
Using in situ hybridization, VEGF receptor-2 (¯k-1/Quek1) and the homologous ¯t-4 (Quek2) receptor were studied in the
CAM of normal quail embryos and after VEGF121 application on the CAM of 11-day-old quail embryos. During normal
development, ¯k-1 expression becomes restricted to vascular endothelial cells of large vessels in the stroma of the CAM.
VEGF121 application induces expression of ¯k-1 in capillaries that normally do not express the receptor. In the normal
development of the CAM, ¯t-4 becomes restricted to endothelial cells of vessels that appear to be lymphatic vessels.
Application of VEGF121 does not alter ¯t-4 expression. q 1996 Academic Press, Inc.
INTRODUCTION Tischer et al., 1989). In the human, these splice forms are
known as VEGF121, VEGF165, VEGF189, and VEGF206. The
Vascular endothelial growth factor (VEGF), also known predominant and most intensely studied form is VEGF165
as vascular permeability factor (VPF), has been isolated from (Fiebich et al., 1993). Except for the smallest form, VEGF
conditioned medium of several cell lines and from tumor is a heparin-binding growth factor (Houck et al., 1992). Ad-
cells (Senger et al., 1983; Ferrara and Henzel, 1989; Gos- ditionally, the two largest forms possess a 24-amino-acid
podarowicz et al., 1989; PloueÈ t et al., 1989; Favard et al., sequence which causes the factors to remain cell-associated
1991; Weindel et al., 1992). VEGF is a secreted dimeric gly- after secretion (Houck et al., 1991).
coprotein that exists in four different forms, generated by Two high-af®nity binding sites for VEGF have been found
to be located almost exclusively on endothelial cells andalternative splicing of the VEGF gene (Leung et al., 1989;
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coli from inclusion bodies according to the procedure describedangioblasts. The two tyrosine-speci®c protein kinase recep-
previously for PDGF homo- and heterodimers (Schneppe et al.,tors are known as ¯t-1 and ¯k-1/KDR (De Vries et al., 1992;
1994). Additionally, VEGF121 was produced using the baculovirusTerman et al., 1991, 1992; Millauer et al., 1993). A pivotal
system in insect cells. Its production and puri®cation have beenrole of the VEGF-¯k-1 signaling for the emergence of hem-
described previously (Fiebich et al., 1993; Cohen et al., 1995). Theangiopoietic cells has recently been shown (Shalaby et al.,
factors were then desalted with a PD-10 column (Pharmacia, Upp-
1995). Targeted disruption of the ¯k-1 gene results in the sala, Sweden) and lyophilized.
development of mice which seem to be completely devoid
of blood islands and endothelial cells. In ¯t-1 mutant mice,
endothelial cells develop, but lumen formation is greatly Embryos
disturbed (Fong et al., 1995). A third receptor, ¯t-4, pos-
Fertilized eggs of the White Leghorn chick (Gallus gallus domes-sesses high homology to VEGF receptors but does not bind
ticus) and the Japanese quail (Coturnix coturnix japonica) were
VEGF (Pajusola et al., 1994). The ligand of ¯t-4 is not incubated at 37.87C and 80% humidity. On Day 5 of chick develop-
known. In the avian, receptors homologous to ¯k-1 and ¯t- ment and Day 3 of quail development, a window was made into
4 have recently been cloned and named Quek1 and Quek2, the eggshell and the embryos were checked for normal develop-
respectively (Eichmann et al., 1993,1996). ment. The window was sealed with cellotape and the eggs were
In the past 20 years, there has been an intensive search further incubated until Day 13 (chick) or Day 11 (quail) of develop-
ment. The lyophilized growth factors were dissolved in sterile dis-for angiogenic factors, based on the observation that tumor
tilled water, and 2±4 mg/5 ml was placed on a tissue culture cov-growth and metastasis is an angiogenesis-dependent process
erslip (Nunc, Naperville, IL) of about 5 mm2. After air-drying, the(Folkman, 1974). Many growth factors have been described
inverted coverslips were placed on the CAM of 13-day-old chickthat appeared to be directly or indirectly involved in angio-
or 11-day-old quail embryos. Following another 2±3 days of incuba-genesis. The screening of angiogenic factors has often been
tion, the CAMs were ®xed in 2.0% formaldehyde and 3.0% glutar-
performed on the chorioallantoic membrane (CAM) of chick aldehyde in 0.12 M cacodylate buffer. They were photographed with
embryos (Folkman, 1974). We have modi®ed the CAM assay transmitted light using a stereomicroscope (Wild M8) and embed-
and applied growth factors on the differentiated CAM of ded in epoxy resin (Fluka, Buchs, Switzerland). Semi- and ultrathin
13-day-old chick embryos (Wilting et al., 1991). This differs sectioning was performed according to standard procedures. As a
from the usual assay, in which growth factors are applied control, coverslips without growth factors were placed on the
CAM. Such controls, as well as the effects or noneffectiveness ofto the developing CAM of 9- or 10-day-old embryos. Of
other growth factors, have been published before (Wilting et al.,several growth factors studied, only VEGF165 turned out to
1991, 1992, 1993; Kurz et al., 1995). A total of 39 experiments werebe a speci®c angiogenic factor (Wilting et al., 1991, 1992,
carried out with VEGF121 , and 12 experiments were carried out1993). The CAM possesses lymphatic vessels that accom-
with VEGF121/165.pany the blood vessels (Romanoff, 1960). Therefore, applica-
tion of growth factors to the CAM also allows one to study
their effect on lymphatic endothelial cells. Proliferation Studies
We have now tested the smallest form of VEGF, VEGF121,
Studies on cell kinetics were performed according to the BrdU±for its angiogenic potential. VEGF121 differs from the larger
anti-BrdU method (Gratzner, 1982). After 2±3 days of growth factorVEGF isoforms in that it is the only VEGF type that does
treatment, the embryos were incubated with 100 ml of a 40 mMnot bind to heparin (Houck et al., 1992). We applied the
BrdU solution (Sigma, Deisenhofen, Germany). After 1 hr, the spec-
homodimeric form of VEGF121 as well as the heterodimeric imens were ®xed overnight in ethanol containing 3% acetic acid.
form VEGF121/165 to the CAM of 13-day-old chick embryos. Whole CAMs or paraf®n sections were stained with an anti-BrdU-
The results were evaluated macroscopically and using semi- antibody, diluted 1:100 (DAKO, Hamburg, Germany). The second
and ultrathin sectioning. Proliferation studies were per- antibody was peroxidase-conjugated goat anti-mouse IgG (Sigma),
formed on whole mounts and paraf®n-embedded specimens diluted 1:250. DAB was used as chromogen.
Thereafter, whole mounts were embedded in epoxy resin andaccording to the BrdU±anti-BrdU method (Gratzner, 1982).
sectioned at 2.5 mm. Paraf®n sections were counterstained withThe interaction between VEGF121 and the receptors ¯k-1
nuclear fast red (Chroma, Stuttgart, Germany).and ¯t-4 was studied in the CAM of 11-day-old quail em-
bryos using in situ hybridization. The results show that
VEGF121, like VEGF165, is a speci®c angiogenic factor, al- Quantitative Evaluations
though slight differences were detectable between both
(a) Fractal dimension, D. Fixed CAM specimens were placedforms. VEGF121 induces expression of ¯k-1 in capillary endo-
in a petri dish with PBS and gently ¯attened with a submersedthelial cells. Lymphatic vessels and expression of ¯t-4 are
coverslip. The petri dish was evenly illuminated from below andnot affected.
viewed through a green ®lter (522.5 nm) and a macro objective (90
mm, 1:8). Specimens were oriented by randomizing rotational angle
and position (within the limits of the CAM piece), and the vascularMATERIAL AND METHODS
pattern was digitized via a B/W CCD camera (Hitachi KP-140),
connected to a PC-based image analysis system (SIS, MuÈ nster, Ger-Growth Factors
many). Images were prepared with fourfold integration, shading
correction, gray value standardization, and micrometer calibrationThe factors tested in this study are VEGF121 homodimer and
VEGF121/165 heterodimer. The factors were produced in Escherichia (resolution, 11.0 mm/pixel). Preprocessed images of the CAM were
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binarized at a ®xed threshold and isolated pixels were eliminated in the capillary layer of each CAM was counted in six randomly
chosen squares of 200-mm edge length with a Zeiss Standard Micro-with a connectivity operation. With a box-counting method (Stoyan
and Stoyan, 1994; Kurz et al., 1994), the outline of the binary vessel scope and Plan-Neo¯uar 116, as described in Kurz et al. (1995).
The Mann±Whitney U test was used two-sided for comparingimage was scanned with boxes that were 2 to 20 pixels in edge
length. The regression line of box edge length, l, vs box number, treated and control CAMs.
N, was calculated in a log±log plot for the entire range. Its negative
slope was used as an estimate of the mean fractal dimension D 
0ln N/ln l (Cross et al., 1994). Values for D indicate the complexity In Situ Hybridization
of the pattern, in this case mostly due to the bifurcation density,
and are expected to be between 1.0 and 2.0. A value close to 1.0 In situ hybridization was performed with probes against endothe-
lial cell-speci®c receptor tyrosine kinases of quail embryos. Theseindicates a plain pattern, whereas a value close to 2.0 indicates a
complex branching pattern. probes have been described recently (Eichmann et al., 1993). They
have been named Quek1 and Quek2. Quek1 possesses 69 and 71%(b) Proliferation density. The density of BrdU-labeled nuclei
FIG. 1. Macroscopic effects. (a) Control. Note that under the carrier disc the vascular pattern of the CAM is not affected. 116. (b) Effect
of VEGF121 . There is brush-like vessel formation (arrows) in the precapillary region. A, artery; V, vein. 116. (c) Effect of VEGF121/165 . The
effect is almost the same as with the homodimer. 116.
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TABLE 1
Fractal Dimension, D, of the CAM Vascular Pattern Following VEGF Application, and in Controls
Factor D Mean D
VEGF121 1.474 1.400 1.375 1.404 1.463 1.507 1.44
VEGF121/165 1.312 1.477 1.507 1.359 1.41
VEGF165 1.515 1.608 1.491 1.622 1.624 1.529 1.56
Controls 1.259 1.228 1.253 1.309 1.276 1.263 1.26
Note. Each D value can be interpreted as a measure of complexity indicating bifurcation density. In the last column, the mean is given
for n  6 (VEGF heterodimer: n  4). Differences between VEGFs and controls, and between VEGF165 and both VEGF121/165 and VEGF121
are signi®cant (Mann ±Whitney test: P  0.01), whereas differences between the latter are not.
identity to the murine ¯k-1 and the human KDR receptor (VEGF by intussusceptive microvascular growth, whereas signs for
receptor-2), respectively (Eichmann et al., 1996). For the sake of sprouting were almost absent. Lymphatic vessels that can
clarity, we will call this receptor ¯k-1 as has been done in studies regularly be found in the CAM were not affected by VEGF121
on quail embryos previously (Flamme et al., 1995a). Quek2 pos- (Fig. 2b).
sesses 70% identity with the human ¯t-4 gene but only 44% with
The BrdU studies on paraf®n sections showed an enor-¯t-1 (VEGF receptor-1) (Eichmann et al., 1996). This strongly sug-
mous increase in labeled nuclei in the VEGF121-treated areagests that Quek2 is the homologue of ¯t-4 and it will hereafter be
of the CAM. Outside this area, the number of labeled cellscalled ¯t-4. The coding sequence of both probes (about 4.500 bp
was the same as in the normal CAM (Figs. 3a and 3b). Aneach) was cloned into pcDNAI/Amp (Invitrogen, San Diego). Lin-
earization was performed with HindIII and SphI (¯k-1) or with Hin- increase in BrdU-labeled cells was also visible when com-
dIII and XhoI (¯t-4) to produce anti-sense and sense probes, respec- paring whole mounts of normal and VEGF121-treated CAMs
tively. The length of the linearized probes was 3.0 kb for ¯k-1 and (Figs. 3c and 3d). The 2.5-mm sections of the BrdU-treated
1.5 kb for ¯t-4. The dig RNA labeling and detection kit (Boehringer, whole mounts showed that the labeled nuclei belonged al-
Mannheim, Germany) was used as recommended. Specimens were most without exception to endothelial cells (Fig. 3e). The
®xed in Serra's solution (Serra, 1946), dehydrated, and embedded
mean labeling density increased from 241/mm2 (range: 114±in paraf®n. Serial 8-mm sections were hybridized at 657C using 1
433) in the normal CAM to 1002/mm2 (range: 888±1142)mg/ml digoxigenin-UTP labeled probes. The sense probes did not
in the VEGF121-treated specimens.reveal any speci®c staining pattern.
The VEGF121/165 heterodimer also elicited an angiogenic
response. Again, a brush-like formation of blood vessels
could be detected in the precapillary region (Fig. 1c), andRESULTS
the fractal dimension increased to a mean value of 1.41
(Table 1). The effect was con®ned to the application area.Irrespective of the production of VEGF121 in E. coli or
The histological evaluation revealed newly formed capillar-with the baculovirus system, a macroscopic response could
ies in the stroma of the CAM, whereas lymphatic vesselsbe detected after applying VEGF121 on the CAM of 13-day-
were not affected (data not shown).old embryos. In all specimens treated with 2 or 4 mg of
In order to study the interaction between exogenouslygrowth factor, a brush-like formation of vessels was found
applied VEGF121 and the tyrosine-speci®c protein kinase re-in the precapillary region (Figs. 1a and 1b). This effect was
ceptors ¯k-1 (VEGFR-2/Quek1) and the homologous ¯t-4not only visible in the application area, but also at a small
(Quek2), we performed in situ hybridization on serial paraf-distance from this area. In the region of the brush-like ves-
®n sections of various developmental stages. With a fewsels, the fractal dimension increased to a mean value of 1.44
exceptions that will be described in a separate study, bothcompared to the value of 1.26 of the normal CAM (Table
receptors were expressed in endothelial cells during devel-1). Semithin sectioning of the CAM showed that in the area
opment. In the CAM of 4-day-old quail embryos, ¯k-1 wasaffected, the stroma was densely ®lled with capillaries (Fig.
expressed in almost all vascular endothelial cells (Fig. 4a).2b), in addition to the intraepithelial capillaries that were
In the differentiated CAM, ¯k-1 became restricted to endo-present in the normal CAM and in the controls (Fig. 2a).
thelial cells of arteries, veins, and, apparently, lymphaticUltrathin sectioning revealed a continuous endothelial lin-
vessels in the stroma of the CAM. Capillary endothelialing of the newly formed capillaries (Fig. 2c). Compared to
cells did not express ¯k-1 anymore (Fig. 4b). VEGF121 in-capillaries of the normal CAM of 16-day-old embryos, the
duced expression of ¯k-1 in capillary endothelial cells inendothelial cells of the VEGF121-treated specimens con-
the application area, whereas outside the application areatained a greater number of mitochondria and micropinocy-
no expression was detectable (Figs. 4c and 4d).totic vesicles (Fig. 2d). Additionally, many slender intralu-
In 2-day-old quail embryos, ¯t-4 was expressed in almostminal cell processes could be seen (Fig. 2e). Fenestrations
all endothelial cells. However, expression became down-could not be detected. From the morphology of the endothe-
lial cells, it appeared that the new capillaries were formed regulated much earlier than that of ¯k-1. In the differenti-
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FIG. 2. (a) Semithin section of a control specimen. Note the location of the capillaries (arrows) in the chorionic epithelium. A, artery; L,
lymphatic vessel; V, vein. 1270. (b) Semithin section showing brush-like vessels in the stroma of a VEGF121 treated CAM. Lymphatic vessels
(L) are not affected. A, artery; C, newly formed capillaries. 1470. (c±e) Ultrathin sections of VEGF121-induced vessel. (c) Low magni®cation
showing the continuous endothelial lining of newly formed vessels. Note intra- and transluminal processes of endothelial cells (arrows).12700.
(d) Activated endothelial cell with many mitochondria (arrows) and vesicles (arrowheads). Note the indented nucleus (N).113,200. (e) Capillary
showing an intraluminal process (arrowhead) and an intraluminal fold (arrow) that is ®lled with collagen ®brils. 16600.
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FIG. 3. Proliferation studies according to the BrdU±anti-BrdU method. (a±b) Paraf®n sections showing a great number of labeled nuclei
in the application area (b), whereas outside the affected area (a) only a few labeled nuclei are present (arrows). 1210. (c±d) Whole mounts
showing a control (c) and a VEGF121-treated specimen (d). Note the higher amount of labeled nuclei in the growth factor-treated specimen.
(e) Semithin section of the specimen shown in d. Labeled nuclei are those of endothelial cells (arrows). 1210.
ated CAM, expression of ¯t-4 was restricted to endothelial receptors have suggested a major role of this growth factor
in embryonic angiogenesis. In avian embryos, VEGF is al-cells that appeared to be those of lymphatic vessels (Fig.
5a). Application of VEGF121 did not alter the expression of ready present in the unincubated blastodisc and on Day 2
it is almost ubiquitously expressed in the embryo (Flamme¯t-4. Inside and outside the application area, ¯t-4-expressing
endothelial cells were very rare (Fig. 5b). et al., 1995a). In mouse embryos, VEGF expression has been
found in early stages in the endoderm, the myocardium, and
the ependymal layer of the neural tube. Later, expression is
down-regulated and switched off, but persists in the kidneyDISCUSSION
glomeruli and the choroid plexus (Breier et al., 1992; Du-
mont et al., 1995).A total of 20±30 angiogenic factors have been described.
Two high-af®nity receptors of VEGF, ¯t-1 and ¯k-1/KDR/However, of these factors, only VEGF and the approxi-
Quek1, are almost exclusively found on endothelial cellsmately 50% homologous placenta growth factor (PlGF)
and angioblasts (Terman et al., 1992; De Vries et al., 1992;seem to have a targeted effect on endothelial cells. In situ
hybridization studies on the expression of VEGF and its Millauer et al., 1993; Eichmann et al., 1993; Flamme et
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FIG. 4. Expression of ¯k-1/Quek1 in normal and VEGF121-treated CAMs of quail embryos. (a) CAM of a 4-day-old embryo. Note the blue
¯k-1 signal in almost all endothelial cells (arrows). 1250. (b) CAM of a 12-day-old embryo. Flk-1 is expressed only in endothelial cells of
arteries (A), veins, and apparently of lymphatic vessels (L). C, capillary plexus. 11150. (c±d) VEGF121-treated specimen. Flk-1 is expressed
in capillary endothelial cells (arrows) in the affected area (c), but not outside the affected area (d). 1470.
FIG. 5. Expression of ¯t-4/Quek2 in normal and VEGF121-treated CAMs of quail embryos. (a) CAM of a 12-day-old quail embryo. Flt-4
is expressed in endothelial cells of lymphatic vessels (L) but not those of capillaries (C), arteries (A), and veins. 11150. (b) VEGF121-treated
CAM. The factor does not induce expression of ¯t-4 in endothelial cells. Arrow, single ¯t-4 expressing endothelial cell. 1470.
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al., 1995a). Exceptionally, monocytes, distinct cells of the respect, we have to ask why VEGF does not induce any
edema in the CAM. However, the dense supply with lym-placenta, and some melanoma cell types also express VEGF
receptors (Clauss et al., 1990; Dumont et al., 1995; Cohen phatic vessels and the high osmotic pressure of the allantoic
¯uid (Romanoff, 1960) obviously prevent edema formationet al., 1995). As will be shown in a subsequent study, a few
other cell types express ¯k-1 during avian development. The in the CAM. During normal development, the vessels of
the CAM grow by intussusception rather than by sproutingrecently found PlGF (Maglione et al., 1991) competes with
VEGF for receptor binding but binds only to ¯t-1 (Hauser (Patan et al., 1993). The former is also the main mechanism
after application of VEGF121 on the CAM. We were not ableand Weich, 1993; Park et al., 1994). Targeted mutation of
the ¯t-1 gene leads to the development of abnormal, nonlu- to detect signs of sprouting, whereas intraluminal projec-
tions and transluminal pillars were numerous.menized blood vessels (Fong et al., 1995), whereas mice
carrying an ¯k-1 deletion obviously do not possess any en- The CAM possesses a dense network of lymphatic vessels
that accompany all blood vessels and drain into the caudaldothelial cells (Shalaby et al., 1995). Whereas the activity
of PlGF is as yet a matter of controversy, VEGF has been lymph heart of the embryo (Romanoff, 1960). Lymphatic
vessels can clearly be recognized in semi- and ultrathin sec-shown to be a speci®c endothelial cell mitogen in vitro
(Conolly et al., 1989). VEGF does not bind to the ¯t-4 recep- tions since these vessels possess pores and the endothelial
cells are even thinner than those of blood vessels. Neithertor which is highly homologous to ¯k-1/KDR and ¯t-1 (Paju-
sola et al., 1994). In mouse embryos, ¯t-4 has been found with VEGF165 (Wilting et al., 1992) nor with VEGF121 is an
effect on lymphatic vessels observable. This is quite aston-on endothelial cells that appeared to be those of lymphatic
vessels (Kaipainen et al., 1995). However, during avian de- ishing since during development ¯k-1/Quek1 is expressed
in lymphatic endothelial cells such as those of lymphaticvelopment, ¯t-4 is transiently expressed in vascular endo-
thelial cells (Eichmann et al., 1993) and, as we will show glands (unpublished results). Again, during development of
the CAM, ¯k-1 is present in endothelial cells that seem toin a separate study, in some nonendothelial cells.
We have studied the effects of several human growth fac- be those of lymphatic vessels. The reason VEGF speci®cally
affects blood vessels of the differentiated CAM seems totors on the CAM of chick embryos. Since we have found
that the carrier discs alone and also salt crystals can induce be that VEGF induces de novo expression of ¯k-1 only in
vascular endothelial cells. Up-regulation of ¯k-1 in endothe-a wheel-spoke vessel pattern in the developing CAM of 9-
to 11-day-old embryos (Wilting et al., 1991), we applied salt- lial cells of avian embryos by VEGF has recently been re-
ported (Flamme et al., 1995b). Here we show that VEGF121free growth factors on the differentiated CAM of 13-day-old
embryos. Angiogenin, platelet-derived growth factor, and even induces ¯k-1 in endothelial cells that normally do not
possess detectable levels of this receptor. This is in goodplatelet-derived endothelial cell growth factor have not elic-
ited an angiogenic response in this assay. The ®rst and main correlation with studies on tumor tissues (Plate et al., 1992).
The expression of ¯t-4/Quek2, which at least during a cer-effect of basic ®broblast growth factor has been to induce
®brocyte proliferation (Wilting et al., 1991, 1992, 1993). In tain developmental period is a marker of lymphatic endo-
thelial cells, is not affected by VEGF.contrast, VEGF165 (Wilting et al., 1992, 1993; Kurz et al.,
1995) and, as shown here, VEGF121 homo- and heterodimers Compared to VEGF165 (Wilting et al., 1993; Kurz et al.,
1995), slight differences can be detected with VEGF121. Bothare speci®c endothelial cell mitogens in vivo. As a result,
new capillaries develop in the precapillary region of the forms induce a brush-like vessel formation in the precapillary
region. However, the effect of VEGF165 and of VEGF121/165 isCAM vessels. Those capillaries that are located in the
stroma of the CAM can clearly be identi®ed as new capillar- always con®ned to the application area beneath the carrier
disc. In contrast, the effects of VEGF121 can additionally beies, since this compartment is almost avascular in the fully
differentiated CAM. This is an important difference in the detected a short distance away from the application site,
suggesting diffusion of the factor. This is consistent withdeveloping CAM, where the capillary plexus is still located
in the mesodermal compartment. Since angiogenesis is gen- the fact that VEGF121 does not have a heparin-binding se-
quence and can freely diffuse out of the cells, whereaserally regarded as the development of new blood vessels,
we doubt that the change of the vascular pattern into a VEGF165 can bind approximately 50% to the cell surface
(Houck et al., 1992). The quanti®cation of our results showswheel-spoke pattern, inducible in the developing CAM, is
a reliable sign for angiogenesis (Wilting et al., 1991). Indeed, that VEGF121 induces a fourfold increase in endothelial cell
proliferation compared to the controls. This value was alsothe fractal dimension of the vascular tree in wheel-spoke
regions is lower than that of the normal CAM (unpublished found for VEGF165 (Wilting et al., 1993; Kurz et al., 1995),
thus con®rming that VEGF121 induces biological responsesresults).
The endothelial cells of the capillaries induced by in vascular endothelial cells apparently similar to those in-
duced by VEGF165 (Houck et al., 1992). The vascular bifurca-VEGF121 are obviously in an activated state. They possess
many mitochondria and micropinocytotic vesicles. Since tion density (fractal dimension), however, was slightly
greater after VEGF165 application (see Table 1). On the otherwe could not detect any fenestrations or pores, the high
permeability induced by VEGF (Senger et al., 1983; Con- hand, we have to consider that, due to diffusion, the affected
area was greater after VEGF121 treatment. Therefore, bothnolly, 1991) seems to be due to transcytosis. It remains to
be determined whether the larger forms of VEGF induce forms are about equally potent in inducing angiogenesis.
In summary, our studies show that VEGF121, likeother structural characteristics of endothelial cells. In this
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Eichmann, A., Marcelle, Ch., BreÂant, Ch., and Le Douarin, N. M.VEGF165, is an angiogenic factor in vivo. It induces speci®-
(1996). Molecular cloning of Quek 1 and 2, two quail vascularcally endothelial cell proliferation. The newly formed capil-
endothelial growth factor (VEGF) receptor-like molecules. Gene,laries possess many mitochondria and micropinocytotic
in press.vesicles. In contrast to VEGF165 , VEGF121 diffuses a short
Favard, C., Moukadiri, H., Dorey, C., Praloran, V., and PloueÈt, J.distance from the application site. VEGF121 induces the ex- (1991). Puri®cation and biological properties of vasculotropin, a
pression of ¯k-1/Quek1 in capillary endothelial cells that new angiogenic cytokine. Biol. Cell 73, 1±6.
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